NCT07514533

The Efficacy and Safety of Pucotenlimab (PD-1) Combined With Becotatugvedotin (EGFR-ADC) in Advanced Cholangiocarcinoma

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: NOT_YET_RECRUITING

Phase: PHASE2

Sponsor: Sir Run Run Shaw Hospital

Condition: Cholangiocarcinoma

Signal summary

Public flags

Status signal: Low Signal

Timeline signals: None

Results signal: Low Signal

Operational burden: rare_population_signal

Stopped reason

Context when available

No stop reason available in the current public record.